Showing results (251-260 of 340) with videos related to
Sort By:
Pageof 34
Medicine|June 1, 2017
Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and databasePei-Chien Tsai, Ta-Wei Liu, Yi-Shan Tsai, et al.World Journal of Gastroenterology|March 17, 2025
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetesMing-Ying Lu, Yu-Ju Wei, Chih-Wen Wang, et al.Journal of Gastroenterology and Hepatology|November 22, 2025
FIB-4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLDYa-Chin Huang, Chih-Wen Wang, Jiun-Chi Huang, et al.Alimentary Pharmacology & Therapeutics|February 19, 2025
Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside AnaloguesTyng-Yuan Jang, Yu-Ting Zeng, Po-Cheng Liang, et al.Journal of the Chinese Medical Association : JCMA|February 13, 2025
Air pollution causes abnormal alanine aminotransferase levels in patients with chronic hepatitis BTyng-Yuan Jang, Yu-Ting Zeng, Po-Cheng Liang, et al.The Kaohsiung Journal of Medical Sciences|November 10, 2023
Air pollution associate with advanced hepatic fibrosis among patients with chronic liver diseaseTyng-Yuan Jang, Chi-Chang Ho, Po-Cheng Liang, et al.Plos One|February 4, 2021
Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antiviralsChuan-Pin Lin, Po-Cheng Liang, Ching-I Huang, et al.Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2024
Role of Air Pollution in Development of Hepatocellular Carcinoma Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside AnaloguesTyng-Yuan Jang, Yu-Ting Zeng, Po-Cheng Liang, et al.Journal of Clinical and Translational Hepatology|August 14, 2023
Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver DiseaseJee-Fu Huang, Pei-Chien Tsai, Ming-Lun Yeh, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 9, 2017
Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohortTa-Wei Liu, Pei-Chien Tsai, Ching-I Huang, et al.Pageof 34